TIGENIX NV has a total of 60 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ROYAL COLLEGE SURGEONS IRELAND, JOHNS HOPKINS SINGAPORE PTE LT and NEOSTEM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | WIPO (World Intellectual Property Organization) | 8 | |
#4 | United States | 7 | |
#5 | Canada | 5 | |
#6 | Israel | 5 | |
#7 | New Zealand | 4 | |
#8 | China | 3 | |
#9 | Norway | 3 | |
#10 | United Kingdom | 2 | |
#11 | Hong Kong | 2 | |
#12 | Germany | 1 | |
#13 | Luxembourg | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Object sterilising | |
#5 | Measuring microorganism processes | |
#6 | Unspecified technologies | |
#7 | Diagnosis and surgery | |
#8 | Analysing materials | |
#9 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Luyten Frank | 34 |
#2 | De Bari Cosimo | 26 |
#3 | Dell Accio Francesco | 25 |
#4 | Muir-Mcleod Paula | 9 |
#5 | Knipper Andreas | 9 |
#6 | Bari Cosimo De | 7 |
#7 | Accio Francesco Dell | 5 |
#8 | Dell'Accio Francesco | 3 |
#9 | Motmans Kris | 2 |
#10 | Kris Motmans | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010092100A1 | Biopsy device | |
GB0904411D0 | Biopsy device | |
GB0902495D0 | Biopsy device | |
US2010068715A1 | Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production | |
NZ589814A | Methods to maintain, improve and restore the cartilage phenotype of chondrocytes | |
EP1653994A2 | Use of cxcl6 chemokine in the prevention or repair of cartilage defects | |
AU2003266282A1 | Compositions comprising muscle progenitor cells and uses thereof | |
US7482114B2 | In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation | |
AU2002308249A1 | Polynucleotide sequences and vectors useful for the prevention or treatment of bone- or cartilage-related disorders | |
EP1282690A1 | Isolation of precursor cells and their use for tissue repair | |
WO0124833A2 | In vivo assay for testing the phenotypic stability |